title: Natriuretic peptides and the Framingham risk score for screening of asymptomatic left ventricular systolic dysfunction in high-risk patients in primary care. The DAVID-BERG study.
authors: CardioVascular Department, Ospedale Papa Giovanni XXIII, Bergamo, Italy. Electronic address: aiacovoni@hpg23.it.
authors: Attilio
authors: A
authors: Iacovoni
authors: Renata
authors: R
authors: De Maria
authors: Antonello
authors: A
authors: Gavazzi
authors: Aurelia
authors: A
authors: Grosu
authors: Alessandra
authors: A
authors: Fontana
authors: Silvia
authors: S
authors: Guideri
authors: Mauro
authors: M
authors: Gori
authors: Paola
authors: P
authors: Ferrari
authors: Alessandro
authors: A
authors: Filippi
authors: Maria Rosaria
authors: MR
authors: Rutili
authors: Luigi
authors: L
authors: Donzelli
authors: Marina
authors: M
authors: Parolini
authors: Michele
authors: M
authors: Senni
mesh_terms: D000368:Aged; D058070:Asymptomatic Diseases / Q000453:epidemiology; D015415:Biomarkers / Q000097:blood; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D045265:Natriuretic Peptides / Q000097:blood*; D011320:Primary Health Care / Q000379:methods*; D011446:Prospective Studies; D012307:Risk Factors; D018487:Ventricular Dysfunction, Left / Q000097:blood* / Q000175:diagnosis* / Q000453:epidemiology
chemical_list: D015415:Biomarkers; D045265:Natriuretic Peptides
keywords: Asymptomatic left ventricular systolic dysfunction; Cardiovascular risk; Heart failure; Natriuretic peptide; Primary care; Screening